Bayer, CureVac to 'join forces' on Covid-19 vaccine candidate

Frankfurt - Under the deal, CureVac will be able to tap Bayer’s expertise and established infrastructure.

By AFP

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Thu 7 Jan 2021, 12:09 PM

Last updated: Thu 7 Jan 2021, 12:10 PM

German pharmaceutical firms Bayer and CureVac said on Thursday that they have joined forces in the development of CureVac’s Covid-19 vaccine candidate.

Under the deal, CureVac will be able to tap Bayer’s expertise and established infrastructure, according to a joint statement.


The agreement “will help us make our vaccine candidate even more rapidly available to as many people as possible,” CureVac chief executive Franz-Werner Haas said.

 

Photo: Reuters
Photo: Reuters
  • Americas

More news from